García VMI, Moreno LM, Carranza MJ

Language: Spanish
References: 7
Page: 332-342
PDF size: 568.09 Kb.

ABSTRACT

Objective: To determine the frequency and factors associated with mental distress due to diabetes.
Materials and Methods: An observational, analytical, prospective case-control study was conducted in a sequential sampling, from October 2022 to September 2023, of diabetic patients treated in an internal medicine outpatient clinic. There were characterized: age, sex, weight, height, body mass index, abdominal circumference, systolic blood pressure, diastolic blood pressure, heart rate, respiratory rate, fasting glucose, 2-h postprandial glucose, glycated hemoglobin, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, history of hypertension, dyslipidemia, vision loss, kidney damage, neuropathy, cardiovascular disease, dental problems, hand and foot problems. Their educational level and time of diabetes diagnosis were determined. Beck’s Depression Inventory and the Diabetes Distress Scale by Polonsky, validated in Spanish, were applied to them to classify those with and without mental illness (cases and controls, respectively).
Results: There were included 89 patients. The prevalence of mental illness due to diabetes was 40.4%, especially in the area of distress by treatment regimen (52.8%). Factors associated with mental distress were: low educational level and comorbidities, such as hypertension and dyslipidemia, as well as complications, such as neuropathy, vision loss and limb problems.
Conclusions: Improving educational level, correcting comorbidities and avoiding complications are the most important factors to prevent mental distress due to diabetes.

REFERENCES

1. Chireh B, Li M, D’Arcy C. Diabetes increases the risk of depression:a systematic review, meta-analysis and estimatesof population attributable fractions based on prospectivestudies. Prev Med Rep 2019; 14: 100822. https:/doi.org.10.1016/j.pmedr.2019.100822

2. Fathalla MF. Types of sampling in a practical guide forhealth researchers. World Health Organization 2004: 51-52.

3. Vázquez-Salas RA, Hubert C, Portillo-Romero AJ, Valdez-Santiago R, et al. Sintomatología depresiva en adolescentesy adultos mexicanos. Ensanut 2022. Salud Publica Mex 2023;65 (supl 1): S117-S125. https://doi.org/10.21149/14827

4. Sommer J, Borgmann SO, Gontscharuk V, Zaharia OP, etal, for the GDS Group. Depression symptoms, wellbeing,health-related quality of life, and diabetes-related distressin novel subtypes of recent-onset diabetes in Germany:a 5-year observational follow-up study. Lancet DiabetesEndocrinol 2024; 12: 890-903. https:/doi.org.10.1016/S2213-8587(24)00234-1

5. Mazzotta VF. Depresión y síndrome metabólico. AlcmeonRev Arg Clín Neuropsiquiátrica 2011; 16 (4): 396-424.

6. Álvarez Álvarez AM, González Suárez RM, Marrero FalcónMA. Papel de la testosterona y el cortisol en el síndromemetabólicoy la diabetes mellitus tipo 2. Rev CubanaEndocrinol 2010; 21 (1): 80-90.

7. Ortíz SM. Propiedades psicométricas de la escala de estréspara diabéticos en una muestra de pacientes diabéticostipo II chilenos. Academia.edu /23541534/